&Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
12,729
+747
+6% +$77.4K 0.01% 1270
2026
Q1
$1.16M Buy
11,982
+2,190
+22% +$225K 0.01% 1211
2025
Q4
$1.04M Buy
9,792
+257
+3% +$29.8K 0.01% 1200
2025
Q3
$1.21M Sell
9,535
-915
-9% -$109K 0.01% 998
2025
Q2
$1.28M Buy
10,450
+5,242
+101% +$599K 0.01% 865
2025
Q1
$525K Buy
5,208
+653
+14% +$63.8K 0.01% 1111
2024
Q4
$415K Sell
4,555
-128
-3% -$12.6K 0.01% 1161
2024
Q3
$453K Buy
4,683
+2,180
+87% +$196K 0.01% 916
2024
Q2
$215K Buy
+2,503
New +$210K 0.01% 824

Other funds holding EHC

&Partners's EHC Position: Q2 2026 in Review

&Partners increased its Encompass Health (EHC) stake by 6.2% in Q2 2026, buying an estimated $77.4K and bringing the position to 12,729 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #1270.

&Partners first reported a position in EHC in Q2 2024 and has held it in 9 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • &Partners held 12,729 shares of Encompass Health worth $1.29M as of Q2 2026.
  • &Partners bought 747 Encompass Health shares in Q2 2026, an estimated $77.4K.
  • Encompass Health made up 0.01% of &Partners's portfolio in Q2 2026, its #1270 holding.
  • &Partners first reported a position in Encompass Health in Q2 2024 and has held it in 9 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.